Wiki
Definitions
The encyclopedia of 3PBIOVIAN brings together key concepts from the biopharma and CDMO industry, covering biotechnology, drug manufacturing, and GMP-compliant processes.
It includes essential definitions related to bioprocess development, recombinant protein production, and advanced therapies, providing context across the full value chain of a CDMO.
A resource designed to help clients, partners, and industry professionals better understand how biopharmaceutical products are developed and manufactured.
A
- Adeno-associated viruses (AAV)
- Adeno-associated viruses vector (AAV vector)
- Adenoviral vector (AdV vector)
- Adenovirus (AdV)
- Adenovirus serotype 5 (Ad5)
- Adherent cell culture
- Advanced therapies
- Advanced therapy medicinal product (ATMP)
- Allogeneic
- Analytical methods development
- Antibody
- Antigen
- Aseptic processing
- Assay Development
- Autologous
B
C
- Capsid
- CAR-T cell therapy
- Cell banking
- Cell culture
- Cell line
- Cell line development (CLD)
- Cell therapy
- Certificate of Analysis (CoA)
- Chemistry, Manufacturing, and Controls (CMC)
- Chromatography
- Clinical trails
- Clinical Trial Authorization (CTA)
- Cold chain
- Contract Development and Manufacturing Organization (CDMO)
- Critical process parameters (CPPs)
- Critical quality attributes (CQAs)
- Cryopreservation
- Current Good Manufacturing Practice (cGMP)
- Cytokines
D
E
F
G
H
I
M
P
- Packaging cell line
- Phase I clinical study
- Phase II clinical study
- Phase III clinical study
- Plasmid DNA
- Platform
- Polymerase Chain Reaction (PCR)
- Post-translational modifications
- Preclinical Studies
- Process Charcaterization
- Process development
- Process Validation
- Promoter
- Proof of Concept (PoC)
- Protein Folding
- Purification